‌

US Patent 9981939 Compounds and uses thereof for the modulation of hemoglobin

Patent 9981939 was granted and assigned to Global Blood Therapeutics on May, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

Global Blood Therapeutics

0

Current Assignee

Global Blood Therapeutics

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Qing Xu0

Zhe Li0

Brian W. Metcalf0

Calvin W. Yee0

Jason R. Harris0

Stephen L. Gwaltney, II0

Date of Patent

May 29, 2018

0

Patent Application Number

147766030

Date Filed

March 10, 2014

0

Patent Citations Received

US Patent 11702405 Chemical compounds

0

US Patent 12103921 Chemical compounds

0

Patent Primary Examiner

Jeffrey S Lundgren

0

Patent abstract

Provide herein are compounds and pharmaceutical compositions suitable as modulators of hemoglobin, methods and intermediates for their preparation, and methods for their use in treating disorders mediated by hemoglobin and disorders that would benefit from tissue and/or cellular oxygenation.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9981939 Compounds and uses thereof for the modulation of hemoglobin

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.